Unacceptable variation in screening colonoscopy
BMJ 2019; 367 doi: https://doi.org/10.1136/bmj.l6384 (Published 13 November 2019) Cite this as: BMJ 2019;367:l6384
Visual summary available
Implications of two studies for frequency of repeat surveillance after negative colorectal cancer tests
Linked Research
Outcomes at follow-up of negative colonoscopy in average risk population
Linked Research
Variation in post-colonoscopy colorectal cancer across colonoscopy providers in English NHS
- Ethna McFerran, post-doctoral researcher in cancer health economics1,
- James F O’Mahony, research assistant professor2,
- Edward Goodall, member of the Northern Ireland Cancer Research Consumer Forum3,
- Mark Lawler, professor of digital health1
- 1Centre for Cancer Research and Cell Biology, School of Medicine, Dentistry and Biomedical Sciences, Queen’s University Belfast, Belfast BT9 7AE, UK
- 2Centre for Health Policy and Management, School of Medicine, Trinity College Dublin, Dublin, Ireland
- 3Northern Ireland Cancer Research Consumer Forum, Belfast City Hospital, Belfast, UK
- Correspondence to: E McFerran e.mcferran{at}qub.ac.uk
Heisser and colleagues’ (doi:10.1136/bmj.l6109) linked meta-analysis of colorectal cancer and adenoma prevalence in the years following a negative colonoscopy shows that while neoplasms (including adenomas) were observed in more than 20% of participants within five years, advanced neoplasms were rare even after 10 years (2.1% in men, 1.8% in women).1 The authors concluded that a 10 year screening interval after negative colonoscopy, as currently recommended,2 could be adequate.1
In a second paper, Burr and colleagues (doi:10.1136/bmj.l6090) quantify rates of colorectal cancer up to three years after a negative colonoscopy in England.3 They report a decreasing incidence of post-colonoscopy cancers over the period of investigation (from 9.0% in 2005 to 6.5% in 2013), but highlight statistically significant variation between colonoscopy providers. Specifically, they find higher rates of post colonoscopy cancers following privately provided colonoscopy, after controlling for certain confounding factors (adjusted odds ratio 1.63 (95% confidence interval 1.39 to 1.91), P<0.01). Rates were also higher among women, older …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.